News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
384,475 Results
Type
Article (24506)
Company Profile (41)
Press Release (359927)
Multimedia
Podcasts (118)
Webinars (13)
Section
Business (121524)
Career Advice (2255)
Deals (17526)
Drug Delivery (67)
Drug Development (42426)
Employer Resources (120)
FDA (8849)
Job Trends (8727)
News (193650)
Policy (17314)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1527)
Academic (1)
Accelerated approval (16)
Adcomms (14)
Allergies (91)
Alliances (33586)
ALS (112)
Alzheimer's disease (995)
Antibody-drug conjugate (ADC) (189)
Approvals (9082)
Artificial intelligence (355)
Autoimmune disease (104)
Automation (27)
Bankruptcy (162)
Best Places to Work (7178)
BIOSECURE Act (6)
Biosimilars (112)
Biotechnology (30)
Bladder cancer (113)
Brain cancer (34)
Breast cancer (418)
Cancer (3190)
Cardiovascular disease (268)
Career advice (1874)
Career pathing (34)
CAR-T (150)
CDC (25)
Cell therapy (469)
Cervical cancer (25)
Clinical research (36680)
Collaboration (1305)
Company closure (1)
Compensation (286)
Complete response letters (24)
COVID-19 (1512)
CRISPR (62)
C-suite (464)
Cystic fibrosis (88)
Data (4328)
Decentralized trials (2)
Denatured (42)
Depression (86)
Diabetes (344)
Diagnostics (3650)
Digital health (30)
Diversity (7)
Diversity, equity & inclusion (33)
Drug discovery (178)
Drug pricing (97)
Drug shortages (20)
Duchenne muscular dystrophy (152)
Earnings (58176)
Editorial (46)
Employer branding (15)
Employer resources (103)
Events (57769)
Executive appointments (560)
FDA (10895)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (847)
Gene editing (130)
Generative AI (41)
Gene therapy (411)
GLP-1 (593)
Government (2451)
Grass and pollen (6)
Guidances (328)
Healthcare (10501)
HIV (47)
Huntington's disease (30)
IgA nephropathy (61)
Immunology and inflammation (152)
Immuno-oncology (37)
Indications (86)
Infectious disease (1659)
Inflammatory bowel disease (123)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (154)
Interviews (424)
IPO (8424)
IRA (31)
Job creations (1844)
Job search strategy (1544)
JPM (46)
Kidney cancer (8)
Labor market (62)
Layoffs (284)
Leadership (32)
Legal (4443)
Liver cancer (45)
Longevity (10)
Lung cancer (435)
Lymphoma (267)
Machine learning (25)
Management (34)
Manufacturing (489)
MASH (120)
Medical device (6887)
Medtech (6918)
Mergers & acquisitions (9793)
Metabolic disorders (837)
Multiple sclerosis (112)
NASH (9)
Neurodegenerative disease (191)
Neuropsychiatric disorders (51)
Neuroscience (1757)
NextGen: Class of 2026 (3615)
Non-profit (2829)
Now hiring (27)
Obesity (362)
Opinion (211)
Ovarian cancer (93)
Pain (118)
Pancreatic cancer (138)
Parkinson's disease (165)
Partnered (24)
Patents (287)
Patient recruitment (249)
Peanut (29)
People (29530)
Pharmaceutical (13)
Pharmacy benefit managers (15)
Phase 1 (10994)
Phase 2 (15604)
Phase 3 (13099)
Pipeline (3945)
Policy (166)
Postmarket research (1641)
Preclinical (4843)
Press Release (33)
Prostate cancer (203)
Psychedelics (29)
Radiopharmaceuticals (165)
Rare diseases (551)
Real estate (2718)
Recruiting (51)
Regulatory (13056)
Reports (29)
Research institute (1423)
Resumes & cover letters (406)
Rett syndrome (19)
RNA editing (11)
RSV (42)
Schizophrenia (97)
Series A (148)
Series B (97)
Service/supplier (3)
Sickle cell disease (67)
Special edition (14)
Spinal muscular atrophy (84)
Sponsored (29)
Startups (1560)
State (1)
Stomach cancer (10)
Supply chain (54)
Tariffs (38)
The Weekly (75)
Vaccines (602)
Venture capital (48)
Weight loss (228)
Women's health (50)
Worklife (16)
Date
Today (100)
Last 7 days (388)
Last 30 days (1291)
Last 365 days (19065)
2026 (2147)
2025 (19157)
2024 (20406)
2023 (22521)
2022 (28433)
2021 (30244)
2020 (29650)
2019 (25969)
2018 (19125)
2017 (17816)
2016 (17352)
2015 (19740)
2014 (16611)
2013 (14566)
2012 (14424)
2011 (13940)
2010 (12995)
Location
Africa (595)
Alabama (58)
Alaska (4)
Arizona (133)
Arkansas (7)
Asia (22229)
Australia (3687)
California (6649)
Canada (1997)
China (670)
Colorado (315)
Connecticut (330)
Delaware (213)
Europe (52826)
Florida (1100)
Georgia (224)
Hawaii (1)
Idaho (25)
Illinois (504)
India (45)
Indiana (367)
Iowa (10)
Japan (298)
Kansas (73)
Kentucky (16)
Louisiana (15)
Maine (32)
Maryland (855)
Massachusetts (4862)
Michigan (202)
Minnesota (301)
Mississippi (1)
Missouri (56)
Montana (16)
Nebraska (11)
Nevada (77)
New Hampshire (34)
New Jersey (2126)
New Mexico (14)
New York (1887)
North Carolina (902)
North Dakota (5)
Northern California (3197)
Ohio (171)
Oklahoma (14)
Oregon (19)
Pennsylvania (1447)
Puerto Rico (7)
Rhode Island (25)
South America (812)
South Carolina (32)
Southern California (2697)
Tennessee (121)
Texas (1038)
United States (24417)
Utah (224)
Vermont (1)
Virginia (151)
Washington D.C. (54)
Washington State (546)
West Virginia (2)
Wisconsin (62)
Wyoming (2)
384,475 Results for "a and a search staffing".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Novartis Sticks With M&A Strategy of Building Early Pipeline, Searching for Near-Launches
Novartis will still be on the lookout for early-stage deals under $2 billion, and later-stage agreements around a product that could reach the market within five years, CEO Vas Narasimhan said Wednesday.
February 4, 2026
·
2 min read
·
Tristan Manalac
Cancer
Pfizer Searches for Novel Tumor-Selective Antigens With $865M+ Cartography Pact
Cartography will hunt for novel tumor antigens, which Pfizer can opt into and advance into clinical development.
January 7, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Sage’s Search for Lifeline Ran Into Defiant Biogen CEO
After the FDA rejection of Zurzuvae in one type of depression and the triple failure of neuro asset dalzanemdor, Sage was searching for a path forward at the end of December 2024. Biogen CEO Chris Viehbacher spied a possible deal, but the smaller company wasn’t interested.
July 3, 2025
·
3 min read
·
Annalee Armstrong
IN PARTNERSHIP WITH SLONE PARTNERS
How Biotech Funding is Changing Executive Search and Hiring Processes
In this episode presented by Slone Partners, Leslie Loveless, Co-CEO and Managing Partner discusses how hiring and the building of executive teams has responded to the current biotech environment.
November 13, 2025
·
1 min read
·
BioSpace Insights
Drug Development
From Weight Loss to Hair Loss: The Search for the Next Blockbuster
A new generation of companies is eyeing the existing, sizeable hair loss market, hoping that better formulations and new scientific targets will finally produce treatments that are safer and more effective, as well as commercially successful.
November 10, 2025
·
6 min read
·
Ben Hargreaves
Rare Diseases
Ascendis Readies BioMarin Challenge in Achondroplasia While Others Search for Root Cause
Therapies from industry leaders BioMarin and Ascendis Pharma supply a key hormone that promotes bone growth. In order to move the field forward, challengers are looking to address the underlying cause of the rare, genetic disease.
October 13, 2025
·
7 min read
·
Tristan Manalac
Press Releases
Nexus Search Partners Places Switzerland-Based Dr. Vinicius Gomes de Lima as Chief Medical Officer at Azurity Pharmaceuticals
November 20, 2025
·
1 min read
Career Advice
2024 Job Search Toolkit
BioSpace has updated our Job Search Toolkit, including recent resources to help you succeed with your next job search.
July 19, 2024
·
3 min read
·
BioSpace Editorial Staff
FDA
FDA’s Top Cancer Regulator Declined CDER Directorship
The search continues for a new leader for the FDA’s Center for Drug Evaluation and Research after George Tidmarsh resigned on Sunday. Deputy Director Mike Davis is in the running, along with Mary Thanh Hai, currently head of the Office of New Drugs.
November 6, 2025
·
2 min read
·
Tristan Manalac
Cancer
The Search for the Next Keytruda: Immuno-Oncology’s Next Play
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a crossroads, with experts highlighting novel targets, combinations and pre-emptive immunization as the next wave for IO.
March 3, 2025
·
7 min read
·
Heather McKenzie
1 of 38,448
Next
